Home › Esophageal Squamous Cell Carcinoma › Pennsylvania › Philadelphia
Esophageal Squamous Cell Carcinoma clinical trials in Philadelphia, PA
3 studies for Esophageal Squamous Cell Carcinoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RecruitingPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RecruitingPhase 2
- Research Site, Philadelphia
Esophageal Squamous Cell Carcinoma trials in other cities
- Arlington, VA14 studies
- Nashville, TN12 studies
- Houston, TX12 studies
- Los Angeles, CA11 studies
- Baldwin Park, CA8 studies
- West Valley City, UT7 studies
- San Antonio, TX7 studies
- New York City, NY7 studies
- Santa Monica, CA6 studies
- Queens, NY6 studies
- Dallas, TX5 studies
- Boston, MA5 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.